2JX-12164-34156
4 vaccinations
4 coded responses
45 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 871 / NM
- Registered
- 2021-01-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Registered in v-safe
-
2021-01-20
Dose 1 — Moderna
- 2021-01-22
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-20
Survey response — day 28, dose 1MedDRA: Arthralgia — Feeling: FairFree text: Joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
-
2021-04-07
Survey response — day 42, dose 2MedDRA: Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Urinary tract infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-26
- 2021-08-25
-
2021-11-13
Dose 3 — Pfizer-BioNTech
- 2021-11-14
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-22
- 2021-11-28
- 2021-12-06
- 2021-12-12
- 2021-12-20
-
2021-12-27
Survey response — day 42, dose 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-02-10
- 2022-02-13
- 2022-05-16
-
2022-09-23
Dose 4 — Moderna
- 2022-09-23
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-10-03
- 2022-10-07
- 2022-10-14
- 2022-10-23
-
2022-10-28
Survey response — day 35, dose 4MedDRA: Pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, body achesMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
| 4 | 2022-09-23 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-07 | Unsuccessful |
Free text
Release 4 — day 28, dose 1
Symptoms: Joint pain
Release 7 — day 42, dose 2
Symptoms: Urinary tract infection
Release 10 — day 42, dose 3
Symptoms: Runny nose
Release 12 — day 35, dose 4
Symptoms: Runny nose, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release